357 related articles for article (PubMed ID: 20690770)
1. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
2. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
[TBL] [Abstract][Full Text] [Related]
3. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis.
Amathieu R; Nahon P; Triba M; Bouchemal N; Trinchet JC; Beaugrand M; Dhonneur G; Le Moyec L
J Proteome Res; 2011 Jul; 10(7):3239-45. PubMed ID: 21568267
[TBL] [Abstract][Full Text] [Related]
6. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
[TBL] [Abstract][Full Text] [Related]
7. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.
Romero-Gómez M; Ramos-Guerrero R; Grande L; de Terán LC; Corpas R; Camacho I; Bautista JD
J Hepatol; 2004 Jul; 41(1):49-54. PubMed ID: 15246207
[TBL] [Abstract][Full Text] [Related]
8. A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats.
Barba I; Chatauret N; García-Dorado D; Córdoba J
Liver Int; 2008 Sep; 28(8):1141-8. PubMed ID: 18637065
[TBL] [Abstract][Full Text] [Related]
9. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies.
Martínez-Granados B; Morales JM; Rodrigo JM; Del Olmo J; Serra MA; Ferrández A; Celda B; Monleón D
Int J Mol Med; 2011 Jan; 27(1):111-7. PubMed ID: 21072494
[TBL] [Abstract][Full Text] [Related]
11. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
13. Multivariate modeling strategy for intercompartmental analysis of tissue and plasma 1H NMR spectrotypes.
Montoliu I; Martin FP; Collino S; Rezzi S; Kochhar S
J Proteome Res; 2009 May; 8(5):2397-406. PubMed ID: 19317465
[TBL] [Abstract][Full Text] [Related]
14. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
15. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
[TBL] [Abstract][Full Text] [Related]
16. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
[TBL] [Abstract][Full Text] [Related]
17. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
[TBL] [Abstract][Full Text] [Related]
18. Patients with minimal hepatic encephalopathy have poor insight into their driving skills.
Bajaj JS; Saeian K; Hafeezullah M; Hoffmann RG; Hammeke TA
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1135-9; quiz 1065. PubMed ID: 18928938
[TBL] [Abstract][Full Text] [Related]
19. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
Romero-Gómez M; Grande L; Camacho I
Hepatology; 2004 Apr; 39(4):939-43. PubMed ID: 15057897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
